Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Cash for breastfeeding: a new way to boost baby health?

NCT ID NCT07569172

Knowledge-focused Sponsor: Swiss Tropical & Public Health Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study in Côte d'Ivoire tests whether giving mothers a cash reward for breastfeeding until their child is 24 months old increases breastfeeding rates and improves child and maternal health. About 1,040 mothers will either receive the cash incentive or just educational materials. Researchers will track breastfeeding duration, child growth, infections, and maternal well-being.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 1,040 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Feb 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Are enrolled in the Taabo multigenerational birth cohort (MGC) 2. Completed the postpartum interview of the Taabo MGC 3. Have a child who is within two weeks of their 12-month birthday, 4. are breastfeeding at time of recruitment, 5. live in the Taabo HDSS, Côte d'Ivoire 6. have no illnesses that contraindicates breastfeeding, 7. had a healthy singleton infant with a birth weight of at least 2500 grams, and 8. agree to participate and sign an informed consent; if underage (12-17 years), a legal representative will also have to agree to sign the informed consent Exclusion Criteria: 1. Plans to move permanently outside study area 2. Has a medical, intellectual or psychological disability 3. Contraindication for breastfeeding 4. Children born with \< 2500 grams

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Allergies are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

allergic disease anemia atopic eczema Breast Feeding Cough diarrheal disease Eczema hypertensive disorder infectious disease Psychological Well-Being Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Allergies Anemia Antibiotic use Blood pressure Breastfeeding Breastfeeding continuation Breastfeeding duration Breastfeeding education Child development Child growth Coughing Diarrhea Eczema Infectious diseases Mental health Stress Weight loss

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Taabo Health and Demographic Surveillance

    Taabo, Côte d’Ivoire

More trials for these conditions

Other studies related to the condition(s) this trial covers.